Literature DB >> 18298095

Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.

Violeta I Pérez-Nueno1, David W Ritchie, Obdulia Rabal, Rosalia Pascual, Jose I Borrell, Jordi Teixidó.   

Abstract

HIV infection is initiated by fusion of the virus with the target cell through binding of the viral gp120 protein with the CD4 cell surface receptor protein and the CXCR4 or CCR5 co-receptors. There is currently considerable interest in developing novel ligands that can modulate the conformations of these co-receptors and, hence, ultimately block virus-cell fusion. This article describes a detailed comparison of the performance of receptor-based and ligand-based virtual screening approaches to find CXCR4 and CCR5 antagonists that could potentially serve as HIV entry inhibitors. Because no crystal structures for these proteins are available, homology models of CXCR4 and CCR5 have been built, using bovine rhodopsin as the template. For ligand-based virtual screening, several shape-based and property-based molecular comparison approaches have been compared, using high-affinity ligands as query molecules. These methods were compared by virtually screening a library assembled by us, consisting of 602 known CXCR4 and CCR5 inhibitors and some 4700 similar presumed inactive molecules. For each receptor, the library was queried using known binders, and the enrichment factors and diversity of the resulting virtual hit lists were analyzed. Overall, ligand-based shape-matching searches yielded higher enrichments than receptor-based docking, especially for CXCR4. The results obtained for CCR5 suggest the possibility that different active scaffolds bind in different ways within the CCR5 pocket.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298095     DOI: 10.1021/ci700415g

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  10 in total

1.  Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach.

Authors:  Marco A C Neves; Sérgio Simões; M Luisa Sá e Melo
Journal:  J Comput Aided Mol Des       Date:  2010-10-20       Impact factor: 3.686

2.  A novel, customizable and optimizable parameter method using spherical harmonics for molecular shape similarity comparisons.

Authors:  Chaoqian Cai; Jiayu Gong; Xiaofeng Liu; Hualiang Jiang; Daqi Gao; Honglin Li
Journal:  J Mol Model       Date:  2011-07-30       Impact factor: 1.810

Review 3.  Anti-HIV drug development through computational methods.

Authors:  Wan-Gang Gu; Xuan Zhang; Jun-Fa Yuan
Journal:  AAPS J       Date:  2014-04-24       Impact factor: 4.009

Review 4.  Structural Analysis of Chemokine Receptor-Ligand Interactions.

Authors:  Marta Arimont; Shan-Liang Sun; Rob Leurs; Martine Smit; Iwan J P de Esch; Chris de Graaf
Journal:  J Med Chem       Date:  2017-03-10       Impact factor: 7.446

5.  Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure.

Authors:  Bryan D Cox; Anthony R Prosser; Brooke M Katzman; Ana A Alcaraz; Dennis C Liotta; Lawrence J Wilson; James P Snyder
Journal:  Chembiochem       Date:  2014-07-02       Impact factor: 3.164

6.  Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis.

Authors:  Jie Xia; Terry-Elinor Reid; Song Wu; Liangren Zhang; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2018-05-08       Impact factor: 4.956

Review 7.  Chemokine receptors and other G protein-coupled receptors.

Authors:  David T Lodowski; Krzysztof Palczewski
Journal:  Curr Opin HIV AIDS       Date:  2009-03       Impact factor: 4.283

8.  Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.

Authors:  Clara Recasens-Zorzo; Teresa Cardesa-Salzmann; Paolo Petazzi; Laia Ros-Blanco; Anna Esteve-Arenys; Guillem Clot; Martina Guerrero-Hernández; Vanina Rodríguez; Davide Soldini; Alexandra Valera; Alexandra Moros; Fina Climent; Eva González-Barca; Santiago Mercadal; Leonor Arenillas; Xavier Calvo; José Luís Mate; Gonzalo Gutiérrez-García; Isolda Casanova; Ramón Mangues; Alejandra Sanjuan-Pla; Clara Bueno; Pablo Menéndez; Antonio Martínez; Dolors Colomer; Roger Estrada Tejedor; Jordi Teixidó; Elias Campo; Armando López-Guillermo; José Ignacio Borrell; Luis Colomo; Patricia Pérez-Galán; Gaël Roué
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

9.  An Agonist of the CXCR4 Receptor Strongly Promotes Regeneration of Degenerated Motor Axon Terminals.

Authors:  Samuele Negro; Giulia Zanetti; Andrea Mattarei; Alice Valentini; Aram Megighian; Giulia Tombesi; Alessandro Zugno; Valentina Dianin; Marco Pirazzini; Silvia Fillo; Florigio Lista; Michela Rigoni; Cesare Montecucco
Journal:  Cells       Date:  2019-09-30       Impact factor: 6.600

10.  Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists.

Authors:  Rama K Mishra; Andrew K Shum; Leonidas C Platanias; Richard J Miller; Gary E Schiltz
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.